Bullboard - Stock Discussion Forum Akero Therapeutics Inc AKRO

Healthcare Biotechnology

Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH), a disease without any approved therapies. Efruxifermin (EFX), is its lead product candidate for MASH, which is being evaluated in the ongoing... see more

Add To Watchlist

NDAQ:AKRO - Post Discussion

Akero Therapeutics Inc > Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Th

View:

Post by whytestocks on Dec 15, 2024 11:00am

Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Th

News; $AKRO Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to ConnectNEW YORK CITY, NY / ACCESSWIRE / December 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the Company") (NASDAQ:AKRO). Investors who purchased Akero securities prior to September 13, 2022, and co...AKRO - Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Stockholders to Connect